PA(P-16:0/18:2(9Z,12Z)) | 937723-92-7

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 甘油磷脂
• 英文名称: PA(P-16:0/18:2(9Z,12Z))
• 英文别名: [(2R)-1-[(Z)-hexadec-1-enoxy]-3-phosphonooxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate
• CAS: 937723-92-7
• 化学式: C₃₇H₆₉O₇P
• 分子量: 656.9
• InChiKey: OLCTYLMZTXKGKH-BBNWHMLASA-N

计算性质

• 辛醇/水分配系数(LogP)：
  13
• 重原子数：
  45
• 可旋转键数：
  35
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.81
• 拓扑面积：
  102
• 氢给体数：
  2
• 氢受体数：
  7

文献信息

• Method for detecting an inflammatory disease or cancer
  申请人：Shan Lian

  公开号：US20080020472A1

  公开（公告）日：2008-01-24

  A method of detecting an inflammatory disease or a cancer in a test subject comprising determining the amount of plasmenyl-PE or a biomarker having a mass charge ratio of approximately 698.2, 722.2, 726.2 or 750.2 in a sample of bodily fluid taken from the test subject and comparing the amount of plasmenyl-PE (or the biomarker) in the sample of the bodily fluid from the test subject to a range of amounts of plasmenyl-PE (or the biomarker) found in samples of the bodily fluid from a group of normal subjects of the same species as the test subject and lacking the inflammatory disease or the cancer, whereby a change in the amount of the plasmenyl-PE (or the biomarker) (such as a lower amount) in the sample of the bodily fluid from the test subject indicates the presence of the inflammatory disease or the cancer.